Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosis.
Mehmet KanbayAbdullah Burak YildizDimitrie SiriopolSezan VehbiNuri Baris HasbalYavuz E KesginMelisa CelayirFatih SelcukbiricikAdrian CovicMark A PerazellaPublished in: International urology and nephrology (2022)
Use of nephrotoxic drugs and the location of malignancy appear to be common drivers of AKI in patients receiving ICPis for solid organ malignancy. Whether nephrotoxic agents or urinary tract obstruction may favor ICPi-related autoimmunity should be further studied.